跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,515 条关于
“DLL3 BiTE”
全部
3,515
临床试验
3,026
药物
144
机构
14
资讯
331
去年
Sylvester Researchers Advance Novel Immunotherapy for Rare Gynecologic Neuroendocrine Cancers
去年
Novel DLL3-Targeted BiTEs and B7-H3 ADCs Show Promise in Extensive-Stage SCLC Treatment
4个月前
SN BioScience Initiates Global Phase 1b/2 Trial of SNB-101 for Small Cell Lung Cancer with Zero High-Grade Diarrhea Events
去年
DLL3-Targeted Therapies Show Promise for Refractory Small Cell Lung Cancer Despite Clinical Challenges
去年
SCLC Treatment Landscape Evolves with Tarlatamab Approval and Promising Trial Results
2年前
DLL3-Guided Therapies Show Promise in Small-Cell Lung Cancer Treatment
29天前
DLL3 Targeted Therapies Market Poised to Exceed $2 Billion by 2030 as Combination Strategies Accelerate
去年
DLL3-Targeted Therapies Show Promise in Neuroendocrine Prostate Cancer
7个月前
Novel BiTE Immunotherapy Reduces Arterial Plaque in Preclinical Atherosclerosis Study
8个月前
AbbVie Secures $1.1B Deal for Zelgen's DLL3-Targeting Cancer Therapy
第 1 页,共 34 页
上一页
下一页